NCT05803161

Congrong Runtong Oral Liquid in the Treatment of Functional Constipation (Yang-deficiency Type)

A Randomized, Double-blind, Dose-exploration, Parallel-controlled, Multicenter Phase II Clinical Study of Congrong Runtong Oral Liquid in the Treatment of Functional Constipation (Yang-deficiency Type)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 180 (actual)
• Sponsor: Beijing Hospital of Traditional Chinese Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Using a placebo as a control, this study aims to preliminarily evaluate the clinical efficacy of Congrong Runtong oral liquid for the treatment of functional constipation (Yang-deficiency type), explore the optimal dosage of Congrong Runtong oral liquid for functional constipation (Yang-deficiency type) to provide a basis for dosage selection in Phase III clinical trials, and observe the safety of clinical use of Congrong Runtong oral liquid.

Conditions

• Functional Constipation

Interventions

Type	Name	Description
DRUG	Congrong Runtong oral liquid	Congrong Runtong oral liquid：component "total glycosides of Cistanche" extracted and refined from the traditional Chinese medicine Cistanche deserticola
DRUG	Placental Congrong Runtong oral liquid	Placental Congrong Runtong oral liquid

Timeline

• Start date: 2023-03-29
• Primary completion: 2024-04-01
• Completion: 2024-04-01
• First posted: 2023-04-07
• Last updated: 2024-10-28

Locations

1 site across 1 country: China